July - December 2008
Companies are listed in alphabetical order
1 July – 31 December 2008
- Abbott Australasia
67k - Actelion 28k
- Alcon Pharmaceuticals 29k
- Allergan 75k
- AMGEN Australia 177k
- Astrazeneca 461k
- Baxter Healthcare 252k
- Bayer Australia 178k
- Biogen Idec Australia 159k
- Boehringer Ingelheim 219k
- Bristol-Myers Squibb Australia 81k
- Celgene Pty Ltd 42k
- CSL Limited 156k
- Eli Lilly Australia 595k
- Genzyme Australasia Pty Ltd 44k
- Gilead Sciences 49k
- GlaxoSmithKline Australia 127k
- Innovex 26k
- iNova Pharmaceuticals 37k
- Ipsen 56k
- Janssen-Cilag 233k
- Lundbeck 85k
- Merck Serono 49k
- Merck Sharp & Dohme 190k
- Mundipharma 53k
- Norgine 31k
- Novartis Pharmaceuticals 775k
- Novo Nordisk 230k
- Nycomed 77k
- Organon 68k
- Pfizer 258k
- Roche Products 257k
- sanofi-aventis 13493k
- Sanofi Pasteur 23k
- Schering-Plough 222k
- Servier Laboratories 247k
- Smith & Nephew 10k
- Solvay Pharmaceuticals 58k
- UCB Pharma 112k
- Wyeth 131k
Previous Educational Event Reports
Page updated: December 2011